Objective: To study the association between dietary intake of flavonoids and subsequent coronary mortality.
Design: A cohort study based on data collected at the Finnish mobile clinic health examination survey from 1967-72 and followed up until 1992.
Settings: 30 communities from different parts of Finland.
Subjects: 5133 Finnish men and women aged 30-69 years and free from heart disease at baseline.
Main outcome measure: Dietary intake of flavonoids, total mortality, and coronary mortality.
Results: In women a significant inverse gradient was observed between dietary intake of flavonoids and total and coronary mortality. The relative risks between highest and lowest quarters of flavonoid intake adjusted for age, smoking, serum cholesterol concentration, blood pressure, and body mass index were 0.69 (95% confidence interval 0.53 to 0.90) and 0.54 (0.33 to 0.87) for total and coronary mortality, respectively. The corresponding values for men were 0.76 (0.63 to 0.93) and 0.78 (0.56 to 1.08), respectively. Adjustment for intake of antioxidant vitamins and fatty acids weakened the associations for women; the relative risks for coronary heart disease were 0.73 (0.41 to 1.32) and 0.67 (0.44 to 1.00) in women and men, respectively. Intakes of onions and apples, the main dietary sources of flavonoids, presented similar associations. The relative risks for coronary mortality between highest and lowest quarters of apple intake were 0.57 (0.36 to 0.91) and 0.81 (0.61 to 1.09) for women and men, respectively. The corresponding values for onions were 0.50 (0.30 to 0.82) and 0.74 (0.53 to 1.02), respectively.
Conclusion: The results suggest that people with very low intakes of flavonoids have higher risks of coronary disease.
Paul Knekt,head of laboratory,a Ritva Jarvinen,lecturer,b Antti Reunane,head of laboratory,a Jouni Maatela,chief physician c
a National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland
b Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland
c Research and Development Centre, Social Insurance Institution, Helsinki and Turku, Finland
PROSTA Q COMPLEX
60 545mg capsules (30-day supply)
Clinically proven Prosta-Q is a specially formulated blend of bioflavonoids shown to have antioxidant, anti-inflammatory, and anti-microbial effects.
$39.99
3 MONTHS SUPPLY OF PROSTA Q COMPLEX
180 545mg capsules (90-day supply)
Clinically proven Prosta Q is a specially formulated blend of bioflavOnoids shown to have antioxidant, anti-inflamMatory, and anti-microbial effects.
$99.99
Q-UROL COMPLEX
60 900mg tablets (30-day supply)
Q-Urol contains all the same ingredients as Prosta-Q plus Bee Pollen and Pumpkin Seed in a higher potency time-release formula.
$59.99
CYSTA Q COMPLEX
60 540mg capsules (30-day supply)
Cysta Q is a dietary supplement that was specifically developed to address the symptoms associated with Interstitial Cystitis and Vulvodynia.
$39.99
3 MONTHS SUPPLY OF CYSTA Q COMPLEX
180 540mg capsules (90-day supply)
Cysta Q is a dietary supplement that was specifically developed to address the symptoms associated with Interstitial Cystitis and Vulvodynia.
$99.99